“We transitioned from science fiction to real products when we launched our first Ekso, and it's only gotten better.”
—Russ Angold
Today, Ekso Bionics® (EKSO) is a worldwide pioneer in the field of robotic exoskeletons. For over 10 years we have been committed to developing the latest technology and engineering to help people rethink current physical limitations and achieve the remarkable. Our products unlock human strength, endurance, and mobility potential, with broad applications across medical and industrial markets. In 2016, Ekso Bionics received the first FDA clearance exoskeleton for use with stroke and spinal cord injury levels to C7. We have yet to imagine all human robotics applications and remain committed to forming strategic partnerships for cutting-edge innovation. Ekso Bionics is headquartered in Northern California and listed on the NASDAQ under the symbol EKSO.
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial commercial applications.
Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities.